3
Researchers have identified a promising new strategy to treat autoimmune diseases by targeting a specific molecular interaction within immune cells. Scripps Research scientists have created a new group of drug compounds that reduce harmful inflammation without weakening the body’s ability to fight infections, a major challenge in treating autoimmune diseases. These compounds, known as ENDOtollins, […]
Source link
